One of Europe’s leading cannabis seed banks, Royal Queen Seeds, has become the first seed bank to offer true F1 cannabis hybrids.
F1 cannabis seeds are characterized by offering growers stable, consistent, and high yields and increased THC concentrations every time. RQS F1 seeds are bred from pure genetic lines and aim to revolutionize cannabis cultivation by offering stable plants and a consistent end product.
“The new F1 auto-flowering hybrids are robust, uniform and have a beautiful inflorescence structure, almost indistinguishable from a light-dependent cannabis plant.”
The new F1 hybrids could change the rules of the game in the cannabis industry, just as feminized seeds did in the 1990s.
The creation of Royal Queen Seeds’ F1 hybrids began in 2016, when the bank created its first pure genetic lines (IBLs) with exceptional growth traits. After several more improvements, RQS crossed its IBLs to create the world’s first true F1 cannabis hybrids that could revolutionize the cannabis industry.
Read more about Royal Queen Seeds and find the most important cannabis news in the world with the Hemp.im mobile app.
F1 hybrids are uniform plants
Unlike the cannabis varieties (and their unpredictable phenotypes) that have long served as the basis for both domestic and commercial cannabis cultivation, F1 hybrids are uniform plants that offer myriad benefits to all sectors of the cannabis industry.
patients – who can benefit from standardized varieties high in cannabinoids, terpenes and other compounds found in hemp
commercial growers – who will be able to improve their operations by working with reliable plants that produce higher yields and THC concentrations than conventional seeds
home growers – who will have access to stronger and more productive plants
Royal Queen Seeds has more than 10 years of experience breeding all types of cannabis strains, from Dutch classics like White Widow to modern American strains like Royal Gorilla and even CBD-rich varieties.
Key features of F1 hybrids
- They are uniform plants with stable growth characteristics.
- They have more vigor, resulting in faster growth and greater resistance to adverse conditions and stress.
- They produce higher yields.
- They show higher and more stable production of cannabinoids and terpenes, resulting in a stronger and more stable final product.
- They have a higher THC content.
What are F1 Hybrid seeds
F1 hybrid seeds are created by pollinating two different plants (parents) to create a new variety with specific traits. Genetically, the term is an abbreviation for Filial 1, which means “first children.”
Royal Queen Seeds began developing F1 hybrid seeds in 2016, using a technique that the vegetable industry has used for decades to create uniform products. Breeders select two plants (or genetic lines) with desirable traits – for example, one generates a high yield and the other a high concentration of THC – and then deliberately cross the plants with each other. RQS used the same technology to cross its pure genetic lines, creating a new variety.
Royal Queen Seeds claims that F1 hybrids provide excellent yields and the same exceptional qualities in every harvest. Autoflowering F1 strains include high THC levels, fast flowering, higher yields, and greater stress tolerance.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Jazz Pharmaceuticals’ Leukemia Drug Receives European Commission Approval
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to the development of drugs in neuroscience and oncology. Founded in 2003 in...
Citi Announced a $6 Million Loan to Sempli for SME financing
The credit granted by Citi was given in partnership with high-impact investors and multilateral development organizations. They all seek to...
How Will the Price of Ripple and Cardano Develop in the Next Few Days
The BOLL indicator shows no specific pattern and denotes the support price of $0.4969 and the resistance price of $0.5059,...
RADEEF: a 182 Million Dirham Plan to Combat Flooding in Morocco
RADEEF is also planning major expansion projects. Firstly, it plans to launch work on extending the wastewater treatment plant. The...
How Institutional Investors Feel About Impact Investing
Investors continue to face greenwashing when implementing impact investing. Among their key concerns are misleading or exaggerated impact claims (60%),...
Biotech2 weeks ago
Murcia Puts Out to Tender for €500,000 the Works of the Clinical Trials Unit in Arrixaca
Africa5 days ago
Immorente Invest Maintains its Financial Stability
Biotech2 weeks ago
Asabys Partners Leads a €14 Million Round in Gradient Denervation
Crowdfunding1 day ago
GoodNews Launches a Crowdfunding Campaign on Crowdcube